This study was conducted, and the animals were treated, in accordance with the guidelines of the Association for Research in Vision and Ophthalmology (ARVO) Statement for the Use of Animals in Ophthalmic and Vision Research. All experiments were approved by the committee on animal experimentation of the Cantonal Veterinary Office Zurich (license numbers ZH204/17 and ZH241/17) and performed according to the ethics and animal experimentation bylaws of the Vetsuisse Faculty, University of Zurich, Switzerland. Eight male and eight female, clinically healthy, 8-month-old, commercially crossbred pigmented New Zealand/California rabbits, weighing approximately 4.3 ± 0.245 kg, were used in this study. All animals underwent a complete ocular examination (intraocular pressure [IOP] evaluation via rebound tonometry, slit-lamp biomicroscopy, fluorescein staining, indirect ophthalmoscopy) to rule out the presence of ocular diseases prior to inclusion in this study. The pupils were dilated with topical 1% tropicamide eyedrops (Thea Pharma SA, Schaffhausen, Switzerland).